Neurocrine Biosciences, Inc.
NBIX
$118.78
$1.911.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.32% | -12.37% | 18.20% | -14.18% | 17.35% |
| Total Receivables | 7.70% | -0.42% | 2.76% | 3.88% | 2.60% |
| Inventory | 2.96% | 25.33% | 7.76% | 14.25% | -2.87% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.42% | -7.89% | 1.25% | 19.60% | 2.76% |
| Total Current Assets | -5.03% | -8.09% | 12.38% | -7.18% | 11.95% |
|
|
|||||
| Total Current Assets | -5.03% | -8.09% | 12.38% | -7.18% | 11.95% |
| Net Property, Plant & Equipment | -0.47% | 75.51% | -1.66% | -0.90% | -0.35% |
| Long-term Investments | -- | -6.56% | -- | -- | -- |
| Goodwill | -- | -6.56% | -- | -- | -- |
| Total Other Intangibles | -0.27% | 5.80% | 2.99% | -2.33% | -3.38% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.87% | -2.82% | 6.83% | 11.23% | 5.59% |
| Total Assets | -0.83% | 5.20% | 6.96% | -4.82% | 6.80% |
|
|
|||||
| Total Accounts Payable | 0.00% | 14.94% | -10.73% | 22.79% | -34.51% |
| Total Accrued Expenses | -3.36% | 18.38% | 18.19% | -17.63% | -3.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.32% | 16.67% | -1.69% | -77.57% | -7.23% |
| Total Finance Division Other Current Liabilities | 400.00% | 150.00% | -52.17% | -97.17% | 353.20% |
| Total Other Current Liabilities | 400.00% | 150.00% | -52.17% | -97.17% | 353.20% |
| Total Current Liabilities | 2.99% | 18.15% | 7.83% | -44.10% | 8.87% |
|
|
|||||
| Total Current Liabilities | 2.99% | 18.15% | 7.83% | -44.10% | 8.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.67% | 81.03% | -1.87% | 1.30% | -2.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.27% | 23.11% | -4.32% | 17.10% | 13.36% |
| Total Liabilities | 2.04% | 38.34% | 2.55% | -26.74% | 6.56% |
|
|
|||||
| Common Stock & APIC | -0.89% | -2.62% | 2.66% | 2.36% | 4.80% |
| Retained Earnings | -118.15% | -64.00% | 266.53% | 57.17% | 27.63% |
| Treasury Stock & Other | 55.17% | -60.00% | 480.00% | -24.24% | -52.86% |
| Total Common Equity | -2.09% | -4.75% | 8.36% | 5.16% | 6.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.09% | -4.75% | 8.36% | 5.16% | 6.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.09% | -4.75% | 8.36% | 5.16% | 6.90% |
|
|
|||||